These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2736131)

  • 1. "Sulbactam: worldwide clinical experience": a symposium. XV International Congress of Chemotherapy. Istanbul, Turkey, July 21, 1987. Proceedings.
    APMIS Suppl; 1989; 5():1-69. PubMed ID: 2736131
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulbactam/ampicillin in clinical practice. Proceedings of a symposium. Munich, 17 January 1987.
    Drugs; 1988; 35 Suppl 7():1-94. PubMed ID: 3220006
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of response to cancer therapy. Proceedings of a symposium held at the XVth International Chemotherapy Congress. Istanbul, Turkey, July 19-24, 1987. Proceedings.
    Prog Clin Biol Res; 1988; 276():1-309. PubMed ID: 3174673
    [No Abstract]   [Full Text] [Related]  

  • 4. Rational antibiotic therapy and the position of ampicillin/sulbactam.
    Lode HM
    Int J Antimicrob Agents; 2008 Jul; 32(1):10-28. PubMed ID: 18539004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinical trial with ampicillin and sulbactam in various infections].
    Kanra G; Seçmeer G; Tarim OF; Calikoğlu AS; Ecevit Z; Günel M
    Mikrobiyol Bul; 1988; 22(4):284-95. PubMed ID: 3252119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of sulbactam-ampicillin/sultamicillin in mixed infections.
    Moosdeen F
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S1. PubMed ID: 10526866
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of sulbactam/ampicillin in the treatment of infections at various sites].
    Migliorato D; Consolo A; Migliorato A; Leone E; Canale MP
    G Ital Chemioter; 1987; 34(1-3):47-55. PubMed ID: 3504414
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion of treatment from cefoxitin to ampicillin/sulbactam: experience in a university teaching hospital.
    Kitrenos JG; Rotella DL; Nakasato S
    Adv Ther; 1995; 12(1):30-43. PubMed ID: 10150321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.
    Betrosian AP; Douzinas EE
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Profile of a new antibiotic: the combination sulbactam/ampicillin].
    Barba D; Galante D; Esposito S; Giusti G
    Recenti Prog Med; 1987 Jun; 78(6):274-83. PubMed ID: 3310152
    [No Abstract]   [Full Text] [Related]  

  • 11. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fleroxacin, a long acting fluoroquinolone with broad spectrum activity. International Congress of Chemotherapy. Istanbul, Turkey, 19-24 July 1987. Proceedings.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():1-234. PubMed ID: 3144527
    [No Abstract]   [Full Text] [Related]  

  • 13. New insights into the clinical profile of norfloxacin. Proceedings of a symposium held at the 6th Mediterranean Congress of Chemotherapy. Taormina, Italy, May 22-27, 1988.
    Eur Urol; 1990; 17 Suppl 1():1-51. PubMed ID: 2354708
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance in anaerobic bacteria. Based on a symposium held at the 12th International Congress of Chemotherapy Florence, 22 July 1981.
    J Antimicrob Chemother; 1981 Dec; 8 Suppl D():1-132. PubMed ID: 7338484
    [No Abstract]   [Full Text] [Related]  

  • 15. Teicoplanin--clinical use and laboratory correlation. Based on papers presented at the 15th International Congress of Chemotherapy. Istanbul, Turkey, July 1987.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-148. PubMed ID: 2965120
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with sulbactam/ampicillin in the treatment of obstetric and gynecologic infections. Rio de Janeiro, Brazil, October 25, 1988. Proceedings.
    Suppl Int J Gynecol Obstet; 1989; 2():1-49. PubMed ID: 2803577
    [No Abstract]   [Full Text] [Related]  

  • 17. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology.
    Chan JC
    Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-mediated resistance to beta-lactam antibiotics: a symposium on sulbactam/ampicillin. Cairo, Egypt, April 18-19, 1985.
    Rev Infect Dis; 1986; 8 Suppl 5():S465-650. PubMed ID: 3025995
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sultamicillin in treatment of genito-urinary infections].
    Dutkiewicz S
    Pol Tyg Lek; 1993 Oct; 48 Suppl 2():16-7. PubMed ID: 8008661
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sultamicillin in treatment of odontogenic states, jaw and mouth infections].
    Piekarczyk J
    Pol Tyg Lek; 1993 Oct; 48 Suppl 2():20-1. PubMed ID: 8008663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.